Advertisement

Nitroprusside

  • Adam Schneeweiss
  • Gotthard Schettler
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 72)

Abstract

Nitroprusside, a direct-acting balanced vasodilator affecting both arteries and veins, is effective in short-term management of patients with congestive heart failure, acute myocardial infarction or malignant hypertension, and patients undergoing surgery of the heart or the aorta. It is effective only by intravenous administration and therefore can be used only in hospitalized patients. It is effective in all age groups, from infants to geriatric patients. Its mechanism of action is not known.

Keywords

Acute Myocardial Infarction Cardiac Index Systemic Vascular Resistance Pulmonary Capillary Wedge Pressure Vasodilator Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Miller RR, et al: Clinical use of sodium nitroprusside in chronic ischemic heart disease. Circulation 51:328, 1975.PubMedGoogle Scholar
  2. 2.
    Chatterjee K, et al: Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48:1183, 1973.PubMedGoogle Scholar
  3. 3.
    Franciosa JA, Silverstein SR: Hemodynamic effects of nitroprusside and furosemide in left ventricular failure. Clin Pharmacol Ther 32:62, 1982.PubMedCrossRefGoogle Scholar
  4. 4.
    Packer M, et al: Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy. Circulation 64:506, 1981.PubMedCrossRefGoogle Scholar
  5. 5.
    Packer M, et al: Sustained effectiveness of minoxidil in heart failure after development of tolerance to other vasodilator drugs. Am J Cardiol 48:375, 1981.PubMedCrossRefGoogle Scholar
  6. 6.
    Shah PK, et al: Effects of nitroprusside-induced reduction of elevated preload and afterload on global and regional ventricular function in acute myocardial infarction. Am Heart J 105:531, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Hockings BEF, et al: Randomized controlled trial of vasodilator therapy after myocardial infarction. Am J Cardiol 48:345, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Shenaq SA, et al: Use of nitroprusside during surgery for thoracoabdominal aortic aneurysm. Circulation [Suppl 1] 70:1–7, 1984.CrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • Adam Schneeweiss
    • 1
  • Gotthard Schettler
    • 2
  1. 1.Geriatric Cardiology Research FoundationTel-AvivIsrael
  2. 2.Department of MedicineUniversity of HeidelbergGermany

Personalised recommendations